These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6709132)

  • 1. Changes in the binding to platelets of [3H]imipramine and [3H]yohimbine in normal subjects taking amitriptyline.
    Braddock LE; Cowen PJ; Elliott JM; Fraser S; Stump K
    Neuropharmacology; 1984 Feb; 23(2B):285-6. PubMed ID: 6709132
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of yohimbine and imipramine to platelets in depressive illness.
    Braddock L; Cowen PJ; Elliott JM; Fraser S; Stump K
    Psychol Med; 1986 Nov; 16(4):765-73. PubMed ID: 3029789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin uptake and imipramine binding in rat platelets after chronic dexamethasone and amitriptyline treatment.
    Chan MY; Lee PH
    Pharmacol Res Commun; 1985 Jul; 17(7):619-32. PubMed ID: 2996030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased platelet 3H-imipramine binding sites in classical migraine.
    Geaney DP; Rutterford MG; Elliott JM; Schächter M; Peet KM; Grahame-Smith DG
    J Neurol Neurosurg Psychiatry; 1984 Jul; 47(7):720-3. PubMed ID: 6086845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dieting and weight loss in volunteers increases the number of alpha 2-adrenoceptors and 5-HT receptors on blood platelets without effect on [3H]imipramine binding.
    Goodwin GM; Fraser S; Stump K; Fairburn CG; Elliott JM; Cowen PJ
    J Affect Disord; 1987; 12(3):267-74. PubMed ID: 3038985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 2-adrenoreceptors on human platelets: selective labelling by [3H]clonidine and [3H]yohimbine and competitive inhibition by antidepressant drugs.
    García-Sevilla JA; Hollingsworth PJ; Smnith CB
    Eur J Pharmacol; 1981 Sep; 74(4):329-41. PubMed ID: 6271559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric interaction between the site labeled by [3H]imipramine and the serotonin transporter in human platelets.
    Meyerson LR; Ieni JR; Wennogle LP
    J Neurochem; 1987 Feb; 48(2):560-5. PubMed ID: 3491878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of 5-hydroxytryptamine by blood platelets incubated in plasma from rats and humans treated with amitriptyline and imipramine.
    Tukiainen E
    Med Biol; 1981 Apr; 59(2):121-6. PubMed ID: 7311628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet binding studies in panic disorder.
    Nutt DJ; Fraser S
    J Affect Disord; 1987; 12(1):7-11. PubMed ID: 3033042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet [3H]imipramine and alpha 2-adrenoceptor binding in normal subjects during desipramine administration and withdrawal.
    Healy DT; Paykel ES; Whitehouse AM; White W; Wilton-Cox H; Johnson AL; Theodorou AE; Lawrence K; Horton RW
    Neuropsychopharmacology; 1991 Feb; 4(2):117-24. PubMed ID: 1851012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-nitroimipramine: a selective irreversible inhibitor of [3H] serotonin uptake and [3H] imipramine binding in platelets.
    Rehavi M; Ittah Y; Rice KC; Skolnick P; Goodwin FK; Paul SM
    Biochem Biophys Res Commun; 1981 Apr; 99(3):954-9. PubMed ID: 7247951
    [No Abstract]   [Full Text] [Related]  

  • 12. [3H]Dihydroergocryptine binding to alpha-adrenergic receptors of human platelets. A reassessment using the selective radioligands [3H]prazosin, [3H]yohimbine, and [3H]rauwolscine.
    Motulsky HJ; Insel PA
    Biochem Pharmacol; 1982 Aug; 31(16):2591-7. PubMed ID: 6291538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatment.
    Poirier MF; Loo H; Benkelfat C; Sechter D; Zarifian E; Galzin AM; Schoemaker H; Segonzac A; Langer SZ
    Eur J Pharmacol; 1984 Nov; 106(3):629-33. PubMed ID: 6097464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Vmax of 3H-serotonin uptake but unchanged 3H-imipramine binding in the platelets of untreated hypertensive subjects.
    Kamal LA; Raisman R; Meyer P; Langer SZ
    Life Sci; 1984 May; 34(21):2083-8. PubMed ID: 6328154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific 3H-imipramine binding in human platelets. Influence of age and sex.
    Langer SZ; Briley MS; Raisman R; Henry JF; Morselli PL
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Sep; 313(3):189-94. PubMed ID: 7432551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers.
    Raisman R; Sechter D; Briley MS; Zarifian E; Langer SZ
    Psychopharmacology (Berl); 1981; 75(4):368-71. PubMed ID: 6803282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet MAO inhibition following tricyclic antidepressant therapy.
    Davidson J; Mcleod MN; Linnoila M; Kurland AA; White HL
    Am J Psychiatry; 1978 May; 135(5):603-5. PubMed ID: 645959
    [No Abstract]   [Full Text] [Related]  

  • 18. Imipramine treatment differentially affects platelet 3H-imipramine binding and serotonin uptake in depressed patients.
    Suranyi-Cadotte BE; Quirion R; Nair NP; Lafaille F; Schwartz G
    Life Sci; 1985 Feb; 36(8):795-9. PubMed ID: 3974410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo inhibition of platelet MAO activity by tricyclic antidepressants.
    Sullivan JL; Dackis C; Stanfield C
    Am J Psychiatry; 1977 Feb; 134(2):188-90. PubMed ID: 835743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptamine, a substrate for the serotonin transporter in human platelets, modifies the dissociation kinetics of [3H]imipramine binding: possible allosteric interaction.
    Segonzac A; Raisman R; Tateishi T; Schoemaker H; Hicks PE; Langer SZ
    J Neurochem; 1985 Feb; 44(2):349-56. PubMed ID: 3871227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.